Jan 1996

Founded by Dr. C.Y. Cheng as a contract research laboratory.

Mar 1996

Launched UV filters Octinoxate and Avobenzone. (LCU)

Oct 1997

Built a new GMP plant for APIS and UV filters (LCU)

Apr 2000

Started cGMP production of API’s.

Sep 2000

ISO 9001 compliance certified. (current version 2008)

May 2001

Filed EU DMF’s of Alfacalcidol and Calcitriol.
(EU DMF’s of multiple products now filed in more than 20 countries)

Jun 2002

Filed US DMF of Leflunomide. (Total 26 on file now) 

Nov 2002

Inspected by DOH, Taiwan.
(GMP certificates on 13 products have been granted.)

Nov 2002

Signed supply agreement with Roche Vitamins for the production and supply of cosmetic UV filters (LCU).

Oct 2004

Passed PAI by US FDA on Leflunomide API.

Sep 2005

Generic Leflunomide using our API launched in US
(Total of 6 API’s are now used in US generic formulations.)

Mar 2006

Passed PAI by US FDA on Avobenzone. (LCU)

Sep 2007

Filed COS (CEP) of Calcipotriol with EU. (Total 2 on file now)

Nov 2007

Passed inspection by BSG of Hamburg, Germany.

Jul 2008

Merged with LC United Chemical Corporation.

Jul 2008

Filed Japan DMF (JMF) of Gadodiamide hydrate.

Aug 2008

Certified as a foreign drug manufacturer by the Japanese Authority.

Apr 2009

Passed PAI on Gadodiamide by PMDA of Japan.

Jun 2009

Passed 2nd PAI by FDA on 7 APIs. ( 2 NDAs and 5 ANDAs)

Aug 2009
Nov 2009
Nov 2010

Obtained COS certificate of Calcipotriol Anhydrous.
Listed in Emerging Stocks on Nov. 27, 2009 (stock code: 4746)
Obtained COS certificate of Leflunomide.